Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
D
067080
vs
K
KOSPI 200
Over the past 12 months, Dae Hwa Pharm Co Ltd has underperformed KOSPI 200, delivering a return of -37% compared to KOSPI 200's +56% growth.
Stocks Performance
067080 vs KOSPI 200
Performance Gap
067080 vs KOSPI 200
Performance By Year
067080 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Dae Hwa Pharm Co Ltd
Glance View
Dae Hwa Pharm is a South Korean pharmaceutical company that makes and sells medicines, with a strong focus on external-use products such as patches, plasters, ointments, and other topical treatments. Its lineup also includes prescription drugs and over-the-counter medicines used for pain relief, inflammation, skin care, and other common medical needs. The company earns money by selling these products under its own brands and through pharmaceutical distribution channels. Its main customers are hospitals, clinics, pharmacies, and medical distributors, along with patients who buy certain products for home use. Dae Hwa Pharm sits in the middle of the drug supply chain: it formulates the medicines, manufactures them, and gets them to healthcare sellers rather than running a consumer retail business itself. That makes it more of a specialist manufacturer than a broad drug marketer. What sets the business apart is its emphasis on non-oral dosage forms, especially patches and other applied treatments that deliver medicine through the skin or directly to the affected area. This kind of product needs know-how in drug formulation, adhesive materials, and quality-controlled manufacturing, so the company competes on product design, reliability, and regulatory compliance as much as on brand recognition.